Enhanced benefit from house dust mite immunotherapy in subjects with low serum levels of LILRA5 or CCL25

Allergy. 2024 Nov 9. doi: 10.1111/all.16386. Online ahead of print.

Authors

Véronique Bordas-Le Floch¹, Anja Heider², Duygu Yazici², Sonia Luce¹, Cezmi Akdis², Laurent Mascarell¹

Affiliations

¹ Innovation and Science Department, Stallergenes Greer, Antony, France.
² Swiss Institute of Allergy and Asthma Research (SIAF), Davos, Switzerland.

PMID: 39520177
DOI: 10.1111/all.16386

No abstract available

Keywords: AIT efficacy; house dust mite; serum markers; sublingual immunotherapy.

Publication types

Letter